Importantly, cancer-related CD15/FUT4 is overexpressed in most of metastatic colorectal cancer (mCRC) patients and participates in cetuximab or bevacizumab mechanisms of resistance in mCRC patients [32]. Here, FUT4 is linked to cancer.